I
Indaptus Therapeutics, Inc. (INDP)
NCM – Real vaqt narxi. Valyuta: USD
1.73
-0.03 (-1.70%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NCM – Real vaqt narxi. Valyuta: USD
1.73
-0.03 (-1.70%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Indaptus Therapeutics, Inc., klinik biotexnologiya kompaniyasi, turli xil rakka qarshi va viruslarga qarshi immünoterapiya mahsulotlarini ishlab chiqish bilan shug'ullanadi. Uning yetakchi klinik nomzodi Decoy20 dan iborat bo'lib, u limfoma, gepatotsellyulyar, kolorektal va oshqozon osti bezi o'smalarining, shuningdek, surunkali gepatit B virusi va inson immunitet tanqisligi virusi infektsiyasining yagona agent faolligini va/yoki kombinatsiyalangan terapiya asosidagi chidamli javoblarini ishlab chiqarish uchun ishlatiladi, shuningdek, ilg'or qattiq o'smalarni davolash uchun ham ishlatiladi. Kompaniya avval Intec Parent, Inc. nomi bilan tanilgan va 2021 yil avgust oyida Indaptus Therapeutics, Inc. nomini olgan. Indaptus Therapeutics, Inc. shtab-kvartirasi Nyu-York, Nyu-Yorkda joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Michael J. Newman Ph.D. | Founder, Chief Scientific Officer & Director |
| Mr. Junyi Dai | CEO & Chairman |
| Mr. Walt Addison Linscott Esq. | Chief Operating Officer |
| Mr. Yu Ding | Chief Financial Officer |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-04-24 | 8-K/A | form8-ka.htm |
| 2026-04-23 | 8-K | form8-k.htm |
| 2026-04-03 | 8-K | form8-k.htm |
| 2026-03-24 | 8-K | form8-k.htm |
| 2026-03-17 | 10-K | form10-k.htm |
| 2026-02-27 | 8-K | form8-k.htm |
| 2026-02-12 | DEFA14A | formdefa14a.htm |
| 2026-02-12 | 8-K | form8-k.htm |
| 2026-01-21 | DEF 14A | formdef14a.htm |
| 2026-01-20 | 8-K | form8-k.htm |